Since deficiencies of either ACADVL [8, 77] or CPT2 [59] can cause cardiomyopathy and arrhythmias in newborns and early infancy, the substantial reduction of FA uptake and oxidation in BTHS hearts likely contributes to the cardiomyopathy phenotype. Here, TAFAZZIN is linked to cardiomyopathy.